Literature DB >> 19937220

Eradication of Enterococcus faecalis by phage therapy in chronic bacterial prostatitis--case report.

S Letkiewicz1, R Miedzybrodzki, W Fortuna, B Weber-Dabrowska, A Górski.   

Abstract

The treatment of three patients suffering from chronic bacterial prostatitis who were qualified for an experimental phage therapy protocol managed at the Phage Therapy Unit in Wrocław is described. They had previously been treated unsuccessfully with long-term targeted antibiotics, autovaccines, and laser biostimulation. Rectal application of phage lysates targeted against Enterococcus faecalis cultured from the prostatic fluid gave encouraging results regarding bacterial eradication, abatement of clinical symptoms of prostatitis, and lack of early disease recurrence.

Entities:  

Mesh:

Year:  2009        PMID: 19937220     DOI: 10.1007/s12223-009-0064-z

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  23 in total

1.  FDA approves use of bacteriophages to be added to meat and poultry products.

Authors:  Leslie H Lang
Journal:  Gastroenterology       Date:  2006-11       Impact factor: 22.682

2.  A new concept of the anatomy of the anal sphincter mechanism and the physiology of defecation. III. The longitudinal anal muscle: anatomy and role in anal sphincter mechanism.

Authors:  A Shafik
Journal:  Invest Urol       Date:  1976-01

3.  Partial characterization of Enterococcus faecalis bacteriophage F4.

Authors:  K Nigutová; I Styriak; P Javorský; P Pristas
Journal:  Folia Microbiol (Praha)       Date:  2008-07-27       Impact factor: 2.099

4.  Antibiotic-resistant bugs in the 21st century--a clinical super-challenge.

Authors:  Cesar A Arias; Barbara E Murray
Journal:  N Engl J Med       Date:  2009-01-29       Impact factor: 91.245

5.  Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium.

Authors:  Biswajit Biswas; Sankar Adhya; Paul Washart; Brian Paul; Andrei N Trostel; Bradford Powell; Richard Carlton; Carl R Merril
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

6.  The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network.

Authors:  M S Litwin; M McNaughton-Collins; F J Fowler; J C Nickel; E A Calhoun; M A Pontari; R B Alexander; J T Farrar; M P O'Leary
Journal:  J Urol       Date:  1999-08       Impact factor: 7.450

7.  Naturally occurring bacteriophages lyse a large proportion of canine and feline uropathogenic Escherichia coli isolates in vitro.

Authors:  T Freitag; R A Squires; J Schmid
Journal:  Res Vet Sci       Date:  2007-10-23       Impact factor: 2.534

Review 8.  Bacterial prostatitis.

Authors:  Brian M Benway; Timothy D Moon
Journal:  Urol Clin North Am       Date:  2008-02       Impact factor: 2.241

Review 9.  Chronic bacterial prostatitis (NIH type II): diagnosis, therapy and influence on the fertility status.

Authors:  F M E Wagenlehner; T Diemer; K G Naber; W Weidner
Journal:  Andrologia       Date:  2008-04       Impact factor: 2.775

Review 10.  Antibiotics: potential hazards to male fertility.

Authors:  P N Schlegel; T S Chang; F F Marshall
Journal:  Fertil Steril       Date:  1991-02       Impact factor: 7.329

View more
  28 in total

1.  Isolation and characterization of a novel bacteriophage φ4D lytic against Enterococcus faecalis strains.

Authors:  Sylwia Parasion; Magdalena Kwiatek; Lidia Mizak; Romuald Gryko; Michał Bartoszcze; Janusz Kocik
Journal:  Curr Microbiol       Date:  2012-06-06       Impact factor: 2.188

2.  Isolation and characterization of Klebsiella pneumoniae specific bacteriophages from sewage samples.

Authors:  S Kumari; K Harjai; S Chhibber
Journal:  Folia Microbiol (Praha)       Date:  2010-06-06       Impact factor: 2.099

3.  Phage treatment of human infections.

Authors:  Stephen T Abedon; Sarah J Kuhl; Bob G Blasdel; Elizabeth Martin Kutter
Journal:  Bacteriophage       Date:  2011-03

Review 4.  Implications of Bacteriophage- and Bacteriophage Component-Based Therapies for the Clinical Microbiology Laboratory.

Authors:  Katherine M Caflisch; Robin Patel
Journal:  J Clin Microbiol       Date:  2019-07-26       Impact factor: 5.948

5.  Complete genome sequence of enterococcal bacteriophage SAP6.

Authors:  Young-Duck Lee; Jong-Hyun Park
Journal:  J Virol       Date:  2012-05       Impact factor: 5.103

6.  Can Bacteriophages Replace Antibiotics?

Authors:  Mikael Skurnik
Journal:  Antibiotics (Basel)       Date:  2022-04-26

7.  Bacteriophage-Resistant Mutant of Enterococcus faecalis Is Impaired in Biofilm Formation.

Authors:  Jiazhen Liu; Yanpeng Zhu; Yang Li; Yuwen Lu; Kun Xiong; Qiu Zhong; Jing Wang
Journal:  Front Microbiol       Date:  2022-06-09       Impact factor: 6.064

Review 8.  Molecular mechanisms of enterococcal-bacteriophage interactions and implications for human health.

Authors:  Gregory S Canfield; Breck A Duerkop
Journal:  Curr Opin Microbiol       Date:  2020-07-08       Impact factor: 7.934

9.  Characterization of the deoxynucleotide triphosphate triphosphohydrolase (dNTPase) activity of the EF1143 protein from Enterococcus faecalis and crystal structure of the activator-substrate complex.

Authors:  Ivan I Vorontsov; George Minasov; Olga Kiryukhina; Joseph S Brunzelle; Ludmilla Shuvalova; Wayne F Anderson
Journal:  J Biol Chem       Date:  2011-07-13       Impact factor: 5.157

10.  Improved adsorption of an Enterococcus faecalis bacteriophage ΦEF24C with a spontaneous point mutation.

Authors:  Jumpei Uchiyama; Iyo Takemura; Miho Satoh; Shin-ichiro Kato; Takako Ujihara; Kazue Akechi; Shigenobu Matsuzaki; Masanori Daibata
Journal:  PLoS One       Date:  2011-10-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.